These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 207646)

  • 41. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
    Mori T; Sairenji T
    Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
    Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
    Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
    [No Abstract]   [Full Text] [Related]  

  • 43. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interferon-regulating activity of the CelAgrip drug and its influence on the formation of reactive oxygen species and expression of innate immunity genes in Burkitt's lymphome cells cultures.].
    Narovlyansky AN; Poloskov VV; Ivanova AM; Mezentseva MV; Suetina IA; Russu LI; Chelarskaya ES; Izmest'eva AV; Ospelnikova TP; Zubashev IK; Sarymsakov AA; Ershov FI
    Vopr Virusol; 2020; 65(2):87-94. PubMed ID: 32515564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.
    Klein G; Vilcek J
    J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines.
    Robey WG; Graham BJ; Harris CL; Madden MJ; Pearson GR; Vande Woude GF
    J Gen Virol; 1976 Jul; 32(1):51-62. PubMed ID: 182914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences between soluble complement-fixing antigens derived from P3HR-1, RAJI, and Hk-Ly-28 cell lines.
    Weliky N; Leaman DH; Kallman BJ
    J Natl Cancer Inst; 1975 Mar; 54(3):593-6. PubMed ID: 164559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
    Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
    J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublines.
    Ernberg I; Klein G; Giovanella BC; Stehlin J; McCormick KJ; Andersson-Anvret M; Aman P; Killander D
    Int J Cancer; 1983 Feb; 31(2):163-9. PubMed ID: 6298125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
    Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS
    J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus binding to virus-carrying cell lines is enhanced in the presence of C3 and C3d.
    Wells A; Koide N; Eggertsen G; Lundwall A; Godal T; Steen HB; Klein G
    J Gen Virol; 1984 Mar; 65 ( Pt 3)():507-13. PubMed ID: 6321638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
    zur Hausen H; Fresen KO
    IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.
    Epstein AL; Henle W; Henle G; Hewetson JF; Kaplan HS
    Proc Natl Acad Sci U S A; 1976 Jan; 73(1):228-32. PubMed ID: 174098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro.
    Siegert W; Mönch T; Valet G
    Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
    Qualtiere LF; Chase R; Vroman B; Pearson GR
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
    McConnell I; Klein G; Lint TF; Lachmann PJ
    Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Difference in viral binding between two Epstein-Barr virus substrains to a spectrum of receptor-positive target cells.
    Wells A; Koide N; Klein G
    Int J Cancer; 1981 Mar; 27(3):303-9. PubMed ID: 6270014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular size variation of EBNA is determined by the EB viral genome.
    Gergely L; Sternås L; Dillner J; Klein G
    Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
    Lin JC; Smith MC; Pagano JS
    Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.